Communication challenges in a young man with Hodgkin's disease.
Medoff
E
E
Yale New Haven Hospital, New Haven, Connecticut, USA.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002330:Carmustine / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D011034:Podophyllotoxin / Q000008:administration & dosage; D019172:Transplantation Conditioning; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage; D014826:Vocal Cord Paralysis / Q000150:complications
D003561:Cytarabine; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D011034:Podophyllotoxin; D008558:Melphalan; D002330:Carmustine